Bio-Techne
TECH
#1482
Rank
NZ$19.94 B
Marketcap
$125.52
Share price
-0.37%
Change (1 day)
29.57%
Change (1 year)
Bio-Techne Corporation is an American holding company for biotechnology and clinical diagnostic brands. The company's brands portfolio includes R&D Systems, Novus Biologicals, Tocris Bioscience, ProteinSimple, Exosome Diagnostics, BiosPacific, Cliniqa, Advanced Cell Diagnostics, RNA Medical, Bionostics and BostonBiochem.

EPS for Bio-Techne (TECH)

EPS in 2023 (TTM): $2.55

According to Bio-Techne's latest financial reports the company's current EPS (TTM) is $2.65. In 2022 the company made an earnings per share (EPS) of $2.82 an increase over its 2021 EPS that were of $2.27.

EPS history for Bio-Techne from 1996 to 2023

Annual EPS

Year EPS Change
2023 (TTM)$2.55-9.73%
2022$2.8224.35%
2021$2.2717.98%
2020$1.92-10.94%
2019$2.16101.57%
2018$1.07-17.53%
2017$1.3039.37%
2016$0.93-17.23%
2015$1.13-14.97%
2014$1.321.29%
2013$1.313.68%
2012$1.26-1.97%
2011$1.291.67%
2010$1.277.14%
2009$1.18-1.06%
2008$1.1919.41%
2007$1.0019.1%
2006$0.8410.56%
2005$0.7629.5%
2004$0.5913.05%
2003$0.5268.43%
2002$0.31-17.05%
2001$0.3717.33%
2000$0.3248.51%
1999$0.2123.17%
1998$0.1713.89%
1997$0.1542.57%
1996$0.11

EPS for similar companies or competitors

Company EPS EPS differencediff. Country
$25.88 877.07%๐Ÿ‡บ๐Ÿ‡ธ USA
-$9.65-464.33%๐Ÿ‡บ๐Ÿ‡ธ USA
$9.36 253.50%๐Ÿ‡บ๐Ÿ‡ธ USA
$13.53 410.83%๐Ÿ‡บ๐Ÿ‡ธ USA
$2.45-7.38%๐Ÿ‡ณ๐Ÿ‡ฑ Netherlands
$14.42 444.59%๐Ÿ‡บ๐Ÿ‡ธ USA
-$1.59-159.87%๐Ÿ‡บ๐Ÿ‡ธ USA